Topics

All Topics

On the Road

Major Medical

Protecting Your Family

In the Workplace

Workplace Injuries

Miscellaneous

Miscellaneous

Bayer Pharmaceuticals Suspends Marketing of Trasylol

Jamie Sheller

Attorney
(866) 735-1102 Ext 475

Posted by Jamie ShellerDecember 05, 2007 2:10 PM

Tags: Drug Products

0 Comments

Print Article

At the request of the FDA, Bayer Pharmaceuticals Corp. has agreed to stop marketing Trasylol. Trasylol is a drug that controls bleeding during heart surgery. According to recent studies, using Trasylol over other similar drugs significantly increases the risk of death, kidney failure, stroke or heart problems. The FDA is waiting for the results from a new study being conducted in Canada to determine if stronger measures should be taken. To read more about this topic, visit trasylol marketing

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Philadelphia

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info

Sheller, P.C. (866) 735-1102 Ext 475 www.sheller.com

Jamie Sheller
(866) 735-1102 Ext 475 Email Jamie

Personal Injury Lawyers Serving: Statewide Pennsylvania, Philadelphia, Norristown, Cheltenham, Chester, Drexel Hill, Folsom, Havertown, King of Prussia, Levittown, Radnor, Springfield, Swarthmore, West Chester, Willow Grove

1528 Walnut Street3rd Floor, Philadelphia, Pennsylvania 19102 [ Show Map ]

First Name

Last Name

Phone

Zip

Better Business Bureau Accredited Business

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.